Integrating intravenous oxaliplatin plus oral capecitabine with pelvic radiation for rectal cancer.
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Capecitabine; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- Acronyms OxaliCap-RT
- 31 Jul 2009 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
- 29 Apr 2009 New trial record